Denali Therapeutics (DNLI) Return on Invested Capital (2019 - 2023)

Denali Therapeutics (DNLI) has 5 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2023.

• Return on Invested Capital for Q4 2023 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital slipped to 0.0% in Q4 2023 per DNLI's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q4 2020 and troughed at 0.0% in Q1 2020.
• A 5-year average of 0.0% and a median of 0.0% in 2019 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2020 and 2021: Return on Invested Capital changed 0 bps in 2020, then rose 1 bps in 2021.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2019, then surged by 135 bps to 0.0% in 2020, then plunged by 590 bps to 0.0% in 2021, then slipped by 22 bps to 0.0% in 2022, then soared by 50 bps to 0.0% in 2023.
• Business Quant data shows DNLI's Return on Invested Capital at 0.0% in Q4 2023, 0.0% in Q3 2023, and 0.0% in Q2 2023.